Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2023 Dermatology Update

Skip to the end of the Expertise Menu

Q1-2023 Dermatology Update

The dermatology space has shown to be resilient from macroeconomic conditions that have impacted M&A activity (rising cost of debt, tight credit markets) in other industries. Strategic acquirers, that have recently traded hands to larger private equity funds, have been the most active buyer cohort, accounting for most of the deal activity over the last few quarters. Provident expects M&A activity and valuation ranges to continue at current levels as debt markets eventually settle down.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/04/Q1-2023-Dermatology-Newsletter.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]